The case in front of me: Chengdu · Germany. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
All questions
Newest first. 5.2k questions across 107 tags.
Concretely: 98.2% · tirzepatide · WXT. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
The particulars: Wuxi · South Africa. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
For reference: a U-100 insulin syringe · 60 mg · 8 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that…
The particulars: SOUL · 5 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being invited…
The specifics, since they change the answer: tirzepatide · a wide-pore C18 column · mazdutide. The comparison I want does not seem to exist anywhere in a form I can…
The specifics, since they change the answer: SELECT · headache. I want to understand what this actually establishes, as opposed to what it is being used to imply. My…
It has now persisted for three weeks, which is what moved this from tolerable to worth asking about. I would like the mechanism, because I want to be able to reason…
For reference: AST · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
The lane and the lead time matter as much as the material for what I am doing. I want to understand what this actually establishes, as opposed to what it is being…
The particulars: tirzepatide · Suzhou. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
What I am working with: retatrutide · STEP 1. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
What I am working with: BCH · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Details up front: a GLP-1 receptor agonist · 2.5 mg. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this…
Details up front: SURMOUNT-2 · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
The lane and the lead time matter as much as the material for what I am doing. I would rather over-plan the first cycle and simplify later. I am prepared to do the…
Numbers first: a 29G needle · dulaglutide · 3.33 mg/mL. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
Details up front: cagrilintide · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I have: 98.2% · Janoshik · 97.9% · Janoshik. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Concretely: an ammonium formate mobile phase · liraglutide · a C8 column. This is one of those things that everyone repeats and nobody derives. This matters…
The case in front of me: SUSTAIN-6 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
The case in front of me: a 30G needle · tirzepatide · 6.67 mg/mL. These are treated as interchangeable and I do not think they are. If both are acceptable I would…
Concretely: 10 mg · 5 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the value…
The case in front of me: ecnoglutide · minus 20 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…